Australian Vanadium Ltd has reported improved cost metrics for Project Lumina, its flagship vanadium flow battery (VFB) energy storage initiative, through subsidiary VSUN Energy Pty Ltd. The project now boasts a levelised cost of storage (LCOS) of A$214 per megawatt-hour (MWh) for an eight-hour duration battery, down from a previous estimate of A$251/MWh. This positions Project Lumina’s vanadium-based solution competitively against similar lithium-ion alternatives in the Australian market.
Lisata Therapeutics Inc (NASDAQ:LSTA) said on Thursday it expects a data-rich year ahead as it advances multiple trials of its lead asset, certepetide, a novel peptide-based therapy being tested in a range of solid tumors.
The New Jersey-based company said it remains focused on progressing certepetide through clinical and preclinical studies, with several important data readouts expected over the course of 2025 and into 2026, including results from the second cohort of its ASCEND trial in metastatic pancreatic cancer and preclinical work with Catalent’s antibody-drug conjugate (ADC) platform.
NanoViricides (NYSE-A:NNVC) said on Thursday it has received ethics committee approval in the Democratic Republic of Congo to move forward with a planned Phase II clinical trial of its antiviral drug NV-387 for treating Mpox, a step toward regulatory submission in a region where the disease continues to spread.
The approval, granted by the National Ethics Committee for Health (CNES) under the DRC’s Ministry of Public Health, clears the company to submit a full clinical trial application (CTA) for NV-387, NanoViricides said.
Alvopetro Energy Ltd (TSX-V:ALV, OTC:ALVOF) reported a 41% surge in first-quarter 2025 sales volumes and said its new Canadian oil wells are outperforming expectations, helping to support an organically funded capital program across Brazil and Canada.
The Calgary-based company posted average daily sales of 2,446 barrels of oil equivalent per day (boepd) in the quarter, up from 1,735 boepd a year earlier, fueled by expanded natural gas volumes under an updated long-term sales agreement in Brazil.
Polarean Imaging PLC (AIM:POLX, OTC:PLLWF) has delivered a solid set of full-year numbers, and analysts at Stifel reckon it’s navigating the tough US academic funding environment as well as could be hoped.
The medical imaging specialist posted $3.1 million in revenue for 2024, more than triple the year before and just above guidance.
Shares in MMirriad Advertising PLC (AIM:MIRI, OTCQX:MMDDF) jumped 8% on Thursday morning after the company said talks with potential investors about a lifeline fundraise were still ongoing.
The in-content advertising specialist said it had received initial indications of interest from some investors willing to support a possible equity raise, but cautioned there were no guarantees that any funding would materialise.
Polarean Imaging PLC (AIM:POLX, OTC:PLLWF) reaffirmed its full-year revenue guidance on Thursday, saying it expects to deliver between $5 million and $6 million in 2025, despite sector-wide funding pressures in its core US market.
The company pointed to a strong order backlog, growing clinical demand and an expanded commercial team as reasons for confidence in second-half sales momentum.
American Rare Earths Ltd has fielded robust rare earth mineralisation from its latest channel sampling campaign at the Cowboy State Mine, part of the company’s flagship Halleck Creek Rare Earths Project in Wyoming, US.
“Halleck Creek is shaping up to be the next major rare earths project in the United States,” CEO Chris Gibbs said.